Needham & Company Raises Price Target on Cardiovascular Systems (CSII) to $27 Following 4Q Beat
Tweet Send to a Friend
Needham & Company reiterated a Buy rating on Cardiovascular Systems (NASDAQ: CSII), and raised the price target to $27.00 (from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
